Stock Performance and Market Context
On 18 June 2026, Integrated Proteins Ltd’s share price closed at Rs.152, establishing a new 52-week and all-time high. The stock opened and traded steadily at this peak price throughout the day, registering a daily gain of 1.95%, outperforming the Sensex’s modest 0.05% rise on the same day. Despite underperforming its sector’s solvent extraction segment, which gained 4.26%, the stock’s five-day consecutive rise has delivered an 8.61% return, underscoring consistent upward momentum.
Over longer time frames, the stock’s performance has been exceptional. It has outpaced the Sensex by a wide margin across multiple periods: a 19.83% gain over one month versus the Sensex’s 2.50%, a remarkable 163.20% over three months compared to the Sensex’s 0.64%, and an extraordinary 249.43% over one year against the Sensex’s decline of 5.21%. Year-to-date, Integrated Proteins Ltd has surged 341.86%, while the Sensex has fallen 9.41%. Even over three years, the stock has appreciated by 1,539.70%, dwarfing the Sensex’s 21.79% rise. The ten-year performance is particularly striking, with a gain of 7,002.80% compared to the Sensex’s 189.93%.
Technical Indicators and Trend Analysis
The stock’s technical profile supports the bullish narrative. Integrated Proteins Ltd is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong upward momentum. The overall technical trend is classified as bullish, a status that has been in place since 27 March 2026 when the price was ₹71.33, indicating a sustained positive shift from a previous sideways trend.
Key technical indicators reinforce this outlook: the MACD, Bollinger Bands, KST, and Dow Theory all show bullish signals on both weekly and monthly timeframes. The Relative Strength Index (RSI) presents a bearish weekly reading but no signal monthly, suggesting some short-term caution amid the broader positive trend. Immediate support is identified at the 52-week low of ₹20.71, while the recent 20-day moving average resistance at ₹138.65 has been decisively surpassed, with the stock now testing its 52-week high at ₹152.
Valuation Metrics Reflect Elevated Market Expectations
Valuation multiples for Integrated Proteins Ltd as of 18 June 2026 reveal a premium pricing reflective of strong investor confidence and growth expectations. The price-to-earnings (P/E) ratio stands at a high 569 times trailing twelve months earnings, while the price-to-book value (P/BV) is 13.59 times. Enterprise value multiples are also elevated, with EV/EBITDA and EV/EBIT both at 279.04 times, and EV/Sales at 28.21 times. The EV to capital employed ratio is 13.58 times. Dividend metrics are not applicable, as the company has not declared dividends recently.
Quality and Financial Trends
Integrated Proteins Ltd is assessed as an average quality company based on long-term financial performance. The company exhibits a strong sales growth trajectory, with a five-year compound annual growth rate (CAGR) of 61.22% in sales. However, earnings before interest and tax (EBIT) growth over five years is more modest at 6.65%. The capital structure is sound, with negligible debt levels (average debt to EBITDA of 0.46) and no promoter share pledging, indicating financial prudence.
Return metrics are relatively weak, with an average return on capital employed (ROCE) of -4.21% and return on equity (ROE) of 2.06%, reflecting challenges in translating sales growth into profitability. The tax ratio stands at 14.04%, and the company has not paid dividends, maintaining a payout ratio of zero. Management risk is rated below average, while growth and capital structure are considered average and good, respectively.
Recent Financial Trends and Delivery Volumes
Short-term financial trends show a flat pattern as of March 2026. The company reported its highest quarterly profit after tax (PAT) of ₹0.23 crores, a positive indicator amid a challenging sales environment. However, net sales for the latest six months declined by 73.53% to ₹5.69 crores, signalling a contraction in revenue despite the stock’s strong price performance.
Delivery volumes have shown an upward trend, with a 1-day delivery volume increase of 24.58% compared to the five-day average, and an 8.69% rise over the past month. This suggests growing investor participation in the stock’s recent rally.
Historical Price Range and Market Capitalisation
The stock’s 52-week price range spans from a low of Rs.20.71 to the current high of Rs.152, representing a substantial increase of 633.94% from the low point. Integrated Proteins Ltd is classified as a micro-cap company, reflecting its relatively small market capitalisation within the edible oil sector.
Summary of Market Ratings and Scores
According to MarketsMOJO, Integrated Proteins Ltd holds a Mojo Score of 58.0 and a Mojo Grade of ‘Hold’, upgraded from a previous ‘Sell’ rating on 29 May 2026. This rating reflects a cautious stance amid the stock’s recent gains and valuation levels.
Conclusion
Integrated Proteins Ltd’s ascent to an all-time high of Rs.152 on 18 June 2026 marks a significant milestone in its market journey. The stock’s strong performance over multiple time horizons, supported by bullish technical indicators and a solid sales growth record, underscores its resilience within the edible oil sector. While valuation multiples are elevated and profitability metrics remain modest, the company’s robust price appreciation and sustained upward trend highlight its noteworthy market presence. This achievement encapsulates a period of remarkable growth and investor confidence, positioning Integrated Proteins Ltd as a prominent micro-cap stock in its industry.
